{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:49:23Z","timestamp":1787726963032,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"vor","delay-in-days":137,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.5604\/01.3001.0012.7907","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T06:12:02Z","timestamp":1544767922000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver Failure"],"prefix":"10.1016","volume":"18","author":[{"given":"Jianchun","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manman","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longgen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.5604\/01.3001.0012.7907_bib0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update.","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"key":"10.5604\/01.3001.0012.7907_bib0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2016.10.012","article-title":"Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis.","volume":"66","author":"Arroyo","year":"2017","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7907_bib0020","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.","volume":"61","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7907_bib0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccc.2015.06.009","article-title":"Acute Kidney Injury in Cirrhosis.","volume":"31","author":"Karvellas","year":"2015","journal-title":"Crit Care Clin"},{"key":"10.5604\/01.3001.0012.7907_bib0030","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","article-title":"Kidney biomarkers in cirrhosis.","volume":"65","author":"Francoz","year":"2016","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7907_bib0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.dld.2016.11.001","article-title":"Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis.","volume":"49","author":"Yap","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.5604\/01.3001.0012.7907_bib0040","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/ctr.12394","article-title":"Neutrophil gelatinase-associated lipocalin associated with irreversibility of pre-liver transplant kidney dysfunction.","volume":"28","author":"Aberg","year":"2014","journal-title":"Clin Transplant"},{"key":"10.5604\/01.3001.0012.7907_bib0045","doi-asserted-by":"crossref","first-page":"e0128145","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.","volume":"10","author":"Ariza","year":"2015","journal-title":"PLoS One"},{"key":"10.5604\/01.3001.0012.7907_bib0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2016.03.002","article-title":"Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.","volume":"65","author":"Ariza","year":"2016","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7907_bib0055","first-page":"1168","article-title":"Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels.","volume":"59","author":"Ahn","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.5604\/01.3001.0012.7907_bib0060","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1478-3231.2012.02766.x","article-title":"Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better?","volume":"32","author":"Finkenstedt","year":"2012","journal-title":"Liver Int"},{"key":"10.5604\/01.3001.0012.7907_bib0065","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/TP.0000000000000552","article-title":"Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients.","volume":"99","author":"Allen","year":"2015","journal-title":"Transplantation"},{"key":"10.5604\/01.3001.0012.7907_bib0070","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/liv.12989","article-title":"Pretransplant renal function according to CKD-EPI cystatin C equation is a prognostic factor of death after liver transplantation.","volume":"36","author":"Uguen","year":"2016","journal-title":"Liver Int"},{"key":"10.5604\/01.3001.0012.7907_bib0075","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.29290","article-title":"Plasma Cystatin C is a predictor of renal dysfunction, ACLF and mortality in patients with acutely decompensated liver cirrhosis.","volume":"66","author":"Markwardt","year":"2017","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7907_bib0080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.","volume":"8","author":"Sarin","year":"2014","journal-title":"Hepatol Int"},{"key":"10.5604\/01.3001.0012.7907_bib0085","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/liv.13117","article-title":"Cytokeratin 18-based cell death markers indicate severity of liver disease and prognosis of cirrhotic patients.","volume":"36","author":"Waidmann","year":"2016","journal-title":"Liver Int"},{"key":"10.5604\/01.3001.0012.7907_bib0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cgh.2017.05.041","article-title":"New Developments in Hepatorenal Syndrome.","volume":"16","author":"Mindikoglu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.7907_bib0095","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.3748\/wjg.v20.i20.6262","article-title":"Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments.","volume":"20","author":"CM","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.5604\/01.3001.0012.7907_bib0100","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease.","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7907_bib0105","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","article-title":"Evidence-based incorporation of serum sodium concentration into MELD.","volume":"130","author":"Biggins","year":"2006","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0012.7907_bib0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C.","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.5604\/01.3001.0012.7907_bib0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00011-017-1043-5","article-title":"Resistin and NGAL are associated with inflammatory response, endothelial activation and clinical outcomes in sepsis.","volume":"66","author":"Macdonald","year":"2017","journal-title":"Inflamm Res"},{"key":"10.5604\/01.3001.0012.7907_bib0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nm.2290","article-title":"The Ngal reporter mouse detects the response of the kidney to injury in real time.","volume":"17","author":"Paragas","year":"2011","journal-title":"Nat Med"},{"key":"10.5604\/01.3001.0012.7907_bib0125","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/hep.27447","article-title":"Liver is the major source of elevated serum lipoca-lin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6\/STAT3.","volume":"61","author":"Xu","year":"2015","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7907_bib0130","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/liv.13443","article-title":"Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure.","volume":"37","author":"Maiwall","year":"2017","journal-title":"Liver Int"},{"key":"10.5604\/01.3001.0012.7907_bib0135","doi-asserted-by":"crossref","first-page":"e6949","DOI":"10.1097\/MD.0000000000006949","article-title":"Role of Cystatin C and glomerular filtration rate in diagnosis of kidney impairment in hepatic cirrhosis patients.","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.5604\/01.3001.0012.7907_bib0140","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.3748\/wjg.v20.i21.6573","article-title":"Role of cystatin C and renal resistive index in assessment of renal function in patients with liver cirrhosis.","volume":"20","author":"Culafic","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.5604\/01.3001.0012.7907_bib0145","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/hepr.12508","article-title":"Benefit of cystatin C in evaluation of renal function and prediction of survival in patients with cirrhosis.","volume":"45","author":"Adachi","year":"2015","journal-title":"Hepatol Res"},{"key":"10.5604\/01.3001.0012.7907_bib0150","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/hep.26556","article-title":"Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis.","volume":"59","author":"Mindikoglu","year":"2014","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7907_bib0155","doi-asserted-by":"crossref","first-page":"e0116968","DOI":"10.1371\/journal.pone.0116968","article-title":"Combining serum cystatin C with total bilirubin improves shortterm mortality prediction in patients with HBV-related acute-on-chronic liver failure.","volume":"10","author":"Wan","year":"2015","journal-title":"PLoS One"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119303175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119303175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:41:57Z","timestamp":1761648117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119303175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1665268119303175"],"URL":"https:\/\/doi.org\/10.5604\/01.3001.0012.7907","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver Failure","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/01.3001.0012.7907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}